Results 221 to 230 of about 214,982 (356)

Chronic kidney disease in the primary care setting: A narrative review

Journal of General and Family Medicine, EarlyView.
Abstract Chronic kidney disease (CKD) is a growing public health concern globally, with primary care physicians (PCPs) playing a pivotal role in its early detection and management. This review explores the epidemiology, risk factors, screening strategies, and clinical manifestations of CKD within primary care settings.
Faryal Safdar, Ahsan Aslam
wiley   +1 more source

Influence of glucagon on the synthesis of phosphatidylcholines and phosphatidylethanolamines in monolayer cultures of Rat hepatocytes [PDF]

, 1979
Math J.H. Geelen, J.E.M. Groener, C.G.M. de Haas, L.M.G. Van Golde   +3 more
openalex   +1 more source

Effect of prebiotics on gastrointestinal symptoms and quality of life in children with intestinal failure: A pilot study

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Children with intestinal failure (IF) have a substantial disease burden, with significant gastrointestinal (GI) symptoms, abnormal stool patterns and reduced health‐related quality of life (HRQOL). This study examined the effects of prebiotic supplementation on GI symptoms and HRQOL.
Rut Anne Thomassen, Janne Anita Kvammen, Beint S. Bentsen, Marianne Bratlie, Siv Kjølsrud Bøhn, Hanne Farstad, Christian Kahrs, Linh Ngo, Camilla Nybø, Camilla Sæland, Erling Tjora, Rune Rose Tronstad, Ketil Størdal, Anne Charlotte Brun, Christine Henriksen   +14 more
wiley   +1 more source

New Perspectives in Modulating the Entero-Insular Axis in Pediatric Obesity. [PDF]

Int J Mol Sci
Dira LM, Marin LM, Popa SG, Singer CE, Cosoveanu CS, Donoiu I, Golli AL.   +6 more
europepmc   +1 more source

Rat Strain Differences in Cyclic-AMP Levels in Liver and Epididymal Fat Pad Tissue as Influenced by Glucagon [PDF]

, 1976
Lilly B. Gardner, Elizabeth B. Spannhake, Sheldon Reiser   +2 more
openalex   +1 more source

Delayed presentation of a retained colonic segment in a child with intestinal failure on teduglutide

JPGN Reports, EarlyView.
Abstract Teduglutide is a glucagon‐like peptide 2 (GLP‐2) analogue that was approved by the United States Food and Drug Administration for the treatment of pediatric (>1 year) intestinal failure due to short bowel syndrome in 2019. GLP‐2 analogues promote rapid intestinal adaptation, increasing the absorptive capacity of residual intestine after ...
Rachel C. Bordelon, Sarah J. Varalla, Varaha S. Tammisetti, Mohamed M. Shahin, Amanda Tchakarov, Essam Imseis, Allison L. Speer   +6 more
wiley   +1 more source

Editorial: Global Obesity Rates Continue to Rise with Challenges for New Drug Treatments Including GLP-1 Receptor Agonists. [PDF]

Med Sci Monit
Parums DV.
europepmc   +1 more source

Insulin, glucagon, peptide and amino acid levels following liver transplantation [PDF]

, 1987
Conte, D, Francavilla, A, Kam, I, Lynch, S, Polimeno, L, Reale, L, Starzl, TE, Tedane, E, Todo, S, Van Thiel, DH   +9 more
core  

ULTRASTRUCTURE OF THE A-CELLS OF CAT ISLETS OF LANGERHANS FOLLOWING SYMPATHETIC STIMULATION OF GLUCAGON SECRETION [PDF]

, 1970
A. C. Esterhuizen, Simon L. Howell
openalex   +1 more source

ABILITY OF GLUCAGON TO PRODUCE CARDIAC STIMULATION WITHOUT ARRHYTHMIAS IN HALOTHANE-ANAESTHETIZED ANIMALS

, 1969
Ronald L. Katz, Llynda Hinds, C J Mills
openalex   +1 more source